PRESS RELEASE published on 03/13/2023 at 13:10, 2 years 11 months ago Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc
PRESS RELEASE published on 03/13/2023 at 13:06, 2 years 11 months ago Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
PRESS RELEASE published on 03/10/2023 at 14:23, 2 years 11 months ago Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc
PRESS RELEASE published on 03/10/2023 at 14:21, 2 years 11 months ago Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
PRESS RELEASE published on 03/10/2023 at 14:20, 2 years 11 months ago Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics, Inc.
PRESS RELEASE published on 03/10/2023 at 14:18, 2 years 11 months ago Form 8.3 - The Vanguard Group, Inc.: Devro plc
PRESS RELEASE published on 03/10/2023 at 14:16, 2 years 11 months ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 03/09/2023 at 13:53, 2 years 11 months ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 03/08/2023 at 13:57, 2 years 11 months ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 03/07/2023 at 13:57, 2 years 11 months ago Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Published on 02/21/2026 at 00:45, 15 hours 16 minutes ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 15 hours 31 minutes ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:15, 16 hours 46 minutes ago DigiPower X Announces Closing of Settlement
Published on 02/20/2026 at 23:00, 17 hours 1 minute ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 17 hours 44 minutes ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/21/2026 at 12:00, 4 hours 1 minute ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/20/2026 at 18:36, 21 hours 24 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 21 hours 29 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 22 hours 1 minute ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 19:29, 20 hours 31 minutes ago SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 09:28, 1 day 6 hours ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
Published on 02/20/2026 at 07:30, 1 day 8 hours ago Announcement of share buyback in the context of a share purchase plan
Published on 02/20/2026 at 07:30, 1 day 8 hours ago EURAZEO COMPLETES THE SALE OF EX NIHILO TO L CATTERTON